Symbiotec Pharmalab plans a ₹150 crore IPO to repay debt and expand operations. The company holds a global leadership position in corticost...

In today’s world, investors cannot assume that correlations that worked in the past will work in exactly the same manner now. We are in a p...

Symbiotec Pharmalab has raised Rs 526.20 crore from anchor investors ahead of its Rs 1,757 crore IPO opening August 24. The pharmaceutical ...

Jefferies has initiated coverage on Anthem Biosciences with a Buy rating and Rs 1,050 target, implying around 20% upside. The brokerage is ...

China and Hong Kong stocks rebounded on Thursday, led by healthcare and technology shares, after a sharp selloff in the previous session. F...

Strides Pharma Science shares rise sharply on Thursday after the USFDA issued an Establishment Inspection Report (EIR) for its Bengaluru fa...

Symbiotec Pharmalab will launch its ₹1,757-crore IPO from August 24–27, 2026, with a price band of ₹938–988 per share. The minimum bid is 1...

Biocon shares rose after its US subsidiary received supplemental FDA approval for Yesintek single-dose prefilled autoinjectors in two stren...

The Centre informed the Supreme Court about fast-tracking new aviation rules. These rules under Bharatiya Vayuyan Adhiniyam, 2024, will be ...

Lupin received USFDA approval for generic Pitolisant Tablets, strengthening its US portfolio and specialty generics presence. Shares remain...

Markets extended their losing streak for a fifth consecutive session on Monday. Airtel Payments Bank appointed Shabnam Sinha as its new cha...

Rising grocery and fuel prices are emerging as a political vulnerability for US Republicans ahead of the November midterms. Despite Donald ...

US President Donald Trump has repeatedly blamed predecessors and others for economic, foreign-policy and domestic problems, drawing scrutin...

Jubilant Pharmova shares fell after Q1 profit plunged 45% YoY to Rs 56 crore, despite revenue rising 17% to Rs 2,229 crore. The profit decl...

Britain's regulator approved Eli Lilly's Foundayo pill for weight and diabetes. This treatment is not yet available through the NHS in the ...

President Donald Trump announced an executive order for revised childhood vaccine recommendations. This order promotes spacing out vaccines...

For Indian pharma, the regulatory risk is still real. A US FDA inspection can still cause trouble. A plant making an important product or g...